Selenopeptide nanomedicine ameliorates atherosclerosis by reducing monocyte adhesions and inflammations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selenopeptide nanomedicine ameliorates atherosclerosis by reducing monocyte adhesions and inflammations

Published:2024-03-13 Issue:7 Volume:17 Page:6332-6341
ISSN:1998-0124
Container-title:Nano Research
language:en
Short-container-title:Nano Res.

Author:

Luo Zhen,Jiang Yuxing,Liu Zimo,Guo Lamei,Zhang Li,Rong Hongtao,Duan Zhongyu,Liang Hongwen,Zhang Aili,Wang Lei,Yi Yu,Wang Hao

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12274-024-6547-z.pdf

Reference54 articles.

1. Libby, P. The changing landscape of atherosclerosis. Nature 2021, 592, 524–533.

2. Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352, 1685–1695.

3. Tombling, B. J.; Zhang, Y. H.; Huang, Y. H.; Craik, D. J.; Wang, C. K. The emerging landscape of peptide-based inhibitors of PCSK9. Atherosclerosis 2021, 330, 52–60.

4. Engelen, S. E.; Robinson, A. J. B.; Zurke, Y. X.; Monaco, C. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: How to proceed. Nat. Rev. Cardiol. 2022, 19, 522–542.

5. Chen, W.; Schilperoort, M.; Cao, Y. H.; Shi, J. J.; Tabas, I.; Tao, W. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat. Rev. Cardiol. 2022, 19, 228–249.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selenomethionine-Conjugated Extracellular Vesicles for ROS-Mediated Cell Apoptosis;ACS Applied Nano Materials;2024-06-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3